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Abstract
Background:  There have been many attempts to develop new materials with stability and high
affinity towards immunoglobulins. Some of glycolipids such as gangliosides exhibit a high affinity
toward immunoglobulins. However, it is considerably difficult to develop these glycolipids into the
practical separation ligand due to their limited amounts. We thus focused our attention on the
feasible use of "mannosylerythritol lipid A", a yeast glycolipid biosurfactant, as an alternative ligand
for immunoglobulins, and undertook the investigation on the binding between mannosylerythritol
lipid A (MEL-A) and human immunoglobulin G (HIgG).
Results:  In ELISA assay, MEL-A showed nearly the same binding affinity towards HIgG as that of
bovine ganglioside GM1. Fab of human IgG was considered to play a more important role than Fc
in the binding of HIgG by MEL-A. The bound amount of HIgG increased depending on the attached
amount of MEL-A onto poly (2-hydroxyethyl methacrylate) (polyHEMA) beads, whereas the
amount of human serum albumin slightly decreased. Binding-amount and -selectivity of HIgG
towards MEL-A were influenced by salt species, salt concentration and pH in the buffer solution.
The composite of MEL-A and polyHEMA, exhibited a significant binding constant of 1.43 ×  106 (M-
1) for HIgG, which is approximately 4-fold greater than that of protein A reported.
Conclusions:  MEL-A shows high binding-affinity towards HIgG, and this is considered to be due
to "multivalent effect" based on the binding molar ratio. This is the first report on the binding of a
natural human antibody towards a yeast glycolipid.
Background
Immunoglobulins represent glycoproteins bearing car-
bohydrate-recognition motifs and are widely used for
immunodiagnostics, epitope mapping and therapeutic
applications etc. [1–3]. There have been many attempts
to develop new materials possessing a stability and high
affinity towards immunoglobulins, due to the high cost
of protein-A or -G most commonly used as an affinity lig-
and for the proteins [4].
Glycolipids such as gangliosides and glycosphingolipids
carry out vital functions (i.e., signal transduction, cell
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recognition and cell proliferation) in biomembranes
through protein-carbohydrate interactions [5,6]. Some
of these glycolipids exhibit a high affinity toward glyco-
proteins as a result of "multivalent or cluster effect" and
thus are focused on as a new affinity ligand for immu-
noglobulins [7,8]. Gangliosides like GM1 and GD1a are
known to bind to immunoglobulins [9–11], while asialo-
GM1 and GD3 show a specific binding to IgM and IgG,
respectively [8,12]. The possibility of developing these
membrane glycolipids into the ligand, however, is far
from straightforward due to their limited amounts and
heterogeneity [13].
"Biosurfactants" constitute a variety of microbial extra-
cellular lipids that are produced in large amounts from
inexpensive natural sources [14,15]. We thus focused our
attention on the feasible use of "glycolipid biosur-
factants" as an alternative affinity ligand for IgG, the
most dominant and essential immunoglobulin in mam-
malians.
Mannosylerythritol lipid (MEL), a yeast glycolipid bio-
surfactant, is abundantly produced from vegetable oils
by Candida strains at a yield of 100 gl-1[16,17]. It easily
makes self-assembling properties, which show binding
affinity towards Concanavalin A [18]. More significantly,
MEL induces the cell differentiation of HL-60 human
promyelocytic leukemia cells [19], the outgrowth of neu-
rites of PC12 rat pheochromocytoma cells [20], and the
growth arrest and apoptosis of B16 mouse melanoma
cells [21]. These intriguing activities of MEL are quite
similar to those of gangliosides or glycosphingolipid
[5,6,22], indicating that MEL may also perform the ac-
tivities through a protein-carbohydrate interaction.
Therefore, we undertook the investigation on the bind-
ing between the potential microbial glycolipid and hu-
man IgG (HIgG).
In this report, we describe for the first time that the yeast
glycolipid shows a significant binding affinity towards a
natural polyclonal HIgG. We also report the binding con-
stant and capacity for HIgG of MEL attached onto a pol-
ymer supporting material.
Results
Binding affinity of MEL-A toward HIgG
GM1, which is a glycosphingolipid having one sialic acid,
exhibits binding affinity towards IgG [9–11], and the sial-
ic acid consisting of acetyl and glycerol groups plays an
important role in carbohydrate-protein interactions
[8,23–25]. The binding affinity between HIgG and MEL-
A bearing acetyl and erythritol groups was thus investi-
gated using GM1 as a proper reference.
The optical absorbance at 450 nm, which corresponds to
the bound amount of HIgG, increased along with in-
creases in the inlet amount of glycolipid, and reached to
a binding-plateau (Fig. 2). This is presumably due to the
limitation in the area of the glycolipid layer or in the
presentation geometry [8,12].
In order to elucidate the fragment of HIgG being respon-
sible for the binding to MEL-A, Fab and Fc fragment spe-
cific anti-HIgG were then used instead of the anti-HIgG
whole body as an enzyme-labeled secondary antibody. In
the case of the Fc specific antibody, the observed absorb-
ance was much higher than that of Fab, implying that
mainly the Fab site of HIgG contributes to the binding to
MEL-A and thus hardly interacts with the added Fab
specific antibody.
No direct binding was observed between the above gly-
colipids and secondary antibodies, and no glycolipid was
leaked from the wells during the course of the present as-
say.
Binding of HIgG to MEL-polyHEMA composite
The binding of HIgG to MEL-A was further confirmed
using the prepared composite, considered to minimize
the limitation presumed in the ELISA assay. In this ex-
periment, the binding of HSA to the composite was also
examined; HSA is the most dominant protein in human
serum that is the essential source of HIgG.
The attached amount of MEL-A onto polyHEMA beads
increased with increases in the charged amount of MEL-
A under the conditions employed (Fig. 3). PolyHEMA it-
self showed no selective binding for HIgG and HSA.
However, as expected from the above results, the bound
amount of HIgG to the composite increased depending
on the attached amount of MEL-A, whereas the amount
of HSA slightly decreased (Fig. 4). The bound amount of
HIgG was 2.7-fold higher than that of HSA with the com-
posite bearing 2.99 mg MEL-A per g of polyHEMA.
Effects of salt and pH on the binding of protein to MEL-
polyHEMA composite
The effects of salt concentration and the pH of the phos-
phate buffer on the binding between the composite and
proteins were further examined to address thebinding
mode as well as the maximum binding. Na2SO4 and NaCl
were then used in this study, since these salts are well
known to promote the binding of a protein to its affinity
ligand [26]. The bound amount of HIgG increased with
increases in the Na2SO4 and NaCl concentrations up to 1
M; the addition of Na2SO4 and NaCl into the buffer en-
hanced the bound amount approximately 1.4-fold and
1.1-fold, respectively, compared to that without the salt
(Table 1). The effect of pH was then examined with theBMC Biotechnology 2001, 1:5 http://www.biomedcentral.com/1472-6750/1/5
presence of 1 M of Na2SO4. Acidic or alkaline conditions
enhanced the binding of both HIgG and HSA, but result-
ed in lower selectivities for the two proteins. The bound
amount of HIgG was 4.7-fold higher than that of HSA
with the buffer of pH 6.4 (Table 1).
Binding constant and capacity for HIgG of MEL-polyHE-
MA composite
In order to deduce the binding constant and capacity for
HIgG of the composite, the optimized conditions, pH 6.4
and 1 M, Na2SO4, were obtained. The binding isotherm
was of the Langmuir type; from the equation for the
Langmuir adsorption isotherm (Fig. 5), the binding con-
stant and capacity were estimated to be 1.43 ×  106 M-1
and 12.6 mg HIgG per g of the composite used, respec-
tively.
Conclusions
In this work, we demonstrated that MEL-A exhibits a sig-
nificant binding affinity towards a natural HIgG. The
binding affinity was nearly the same as that observed for
GM1. MEL-A, however, has a different structure from
that of GM1; both the hydrophilic and hydrophobic
groups of the former are much smaller than those of the
latter.
Some of the bindings between gangliosides and glyco-
proteins are enhanced by a "multivalent or cluster ef-
fect"; a simultaneous association of two or more ligands
and receptors [7,8,12,27]. More importantly, the effect is
considerably dependent on the density, orientation and
conformation of the saccharide moieties of gangliosides
[7,8]. We previously demonstrated that MELs efficiently
Figure 1
Structure of mannosylerythritol lipids produced by Candida
antarctica.
Figure 2
Binding assay of human IgG to mannosylerythritol lipid-A and
gangliosides. The glycolipids were attached inside the wells of
microtiter plate. The wells were incubated with 100 µl of
human IgG solution (10 µM) of 10 m M phosphate-buffered
saline (150 mM NaCl, pH 7.2) for 1 hr. After washing, bound
human IgG were detected by a sandwich assay using an
enzyme-labeled anti-human IgG or anti-human IgG Fab frag-
ment or anti-human IgG Fc fragment. MEL-A (-??-) and GM1
(-??-) with anti-human IgG; MEL-A with anti-human IgG Fab
fragment (-??-) and anti-human IgG Fc fragment (-??-). Each
plot is the mean of triplicate. MEL-A, mannosylerythritol
lipid-A
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Figure 3
Attachment of MEL-A onto poly (2-hydroxyethyl methacr-
ylate) beads. Different amounts of MEL-A in methanol were
charged to the mixture of polyHEMA beads (0.35 ± 0.05 g)
and methanol (20 ml). After the solvent was evaporated, the
obtained residue was washed with water and filtrated. The
amount of MEL-A attached onto the beads was determined
by anthrone method after being extracted with a mixture of
chloroform-methanol (2:1). Each plot is the mean of tripli-
cate. MEL-A, mannosylerythritol lipid-A; polyHEMA, poly (2-
hydroxyethyl methacrylate).
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self-assemble to form vesicles, which show a binding af-
finity towards Concanavalin A based on the "multivalent
effect" [18]. This instantly means that MELs have a supe-
rior property on the molecular orientation and packing.
Therefore, MEL-A is likely to position densely inside the
plate well in a regulated manner so as to generate a "mul-
tivalent surface" leading to the interaction with HIgG.
This may compensate for the small saccharide moiety
and provide MEL-A with a similar binding affinity to that
of GM1. Based on the observed binding capacity, the
binding molar ratio between HIgG and MEL-A is ap-
proximately 1:70, supporting the binding is attributed to
the "multivalent effect."
The sialic acid, especially the acetyl and glycerol side
chains in it, plays an important role in the carbohydrate-
protein interactions [8,23–25]. Neiser et al. reported
that the binding affinity of gangliosides towards HIgG
increased depending on the number of sialic acid [24].
Siebert et al. demonstrated that 9-O-acetylated GD1a
bound to a natural polyclonal HIgG via the direct inter-
action between the acetyl group and amino acids in the
binding site of the protein [25]. It is thus likely that the
O-acetyl and erythritol groups in MEL-A have a critical
role on the interaction with HIgG.
Interestingly, HSA exhibited a different behavior on the
binding to MEL-polyHEMA composite from that of
HIgG, indicating a difference in the binding mode be-
tween the two proteins. HSA is one of the representative
proteins that bind to surfaces via hydrophobic-hydro-
phobic interactions [28]. Hence, the binding of HSA may
be attribute to a interaction between the protein and the
hydrophobic part of MEL-A.
It seems reasonable that the binding of HIgG to the com-
posite was significantly enhanced by the addition of
Na2SO4, because the salt more strongly affects the pro-
tein structure than NaCl in the order of the Hofmeister
series [29]. Bagchi and Birbaum demonstrated that the
angle of two Fab fragments of IgG considerably expand-
ed depending on the pH; the angle was changed from "Y-
shape" (arm-collapsed) into "T-shape" (arm-extended)
[30]. The observed pH effect on the HIgG binding might
be due to the shape change, based on the presumption
that the Fab fragment of HIgG is the main binding site
Figure 4
Binding assay of human IgG to mannosylerythritol-A attached
onto poly (2-hydroxyethyl methacrylate) beads. Human IgG
or human serum albumin (1.0 mg) was added to the mixture
of MEL-polyHEMA composite (0.35±0.05 g) bearing different
amounts of MEL-A and 50 mM phosphate buffer (3 ml) in a
polypropylene tube. The tube was incubated for 1 hr and
then centrifuged. The amount of bound protein was calcu-
lated by subtracting the unbound protein from the total
added; the unbound protein was estimated by measuring the
UV absorbance of the supernatant. human IgG (-??-), human
serum albumin (-??-). Each plot is the mean of triplicate. MEL-
A, mannosylerythritol lipid-A; polyHEMA, poly (2-hydroxye-
thyl methacylate).
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Figure 5
The binding isotherm for human IgG to MEL-A attached onto
poly (2-hydroxyethyl methacrylate) beads. Different amounts
of human IgG (0.1 to 12.0 mg) was added to the mixture of
MEL-polyHEMA composite (0.35±0.05 g) bearing 4.04 mg
MEL-A per g of polyHEMA and 50 mM phosphate buffer (1M
of Na2SO4, pH 6.4) (3 ml) in a polypropylene tube. The tube
was incubated for 1 hr and then centrifuged. The amount of
bound protein was calculated by subtracting the unbound
protein from the total added; the unbound protein was esti-
mated by measuring the UV absorbance of the supernatant.
The binding constant and capacity were determined from the
equation for the Langmuir adsorption isotherm, q = (Qmax
KaC) / (1+KaC). MEL-A, mannosylerythritol lipid-A; poly-
HEMA, poly (2-hydroxyethyl methacylate).
C, residual concentration of HIgG (mg/ml)
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towards MEL-A. On the contrary, the Fc fragment of
HIgG is the binding site towards protein A, which is the
most representative affinity ligand for IgG [31]. The
binding mode of MEL-A for HIgG, therefore, is likely to
be significantly different from that of protein A, that is, a
protein-protein interaction.
Teng et al. recently reported that the binding constant
and capacity for HIgG of immobilized protein A (com-
mercially available) were 3.65 ×  105M-1 and 17.0 mg
HIgG per g of the supporting material, respectively [4].
The binding molar ratio between HIgG and protein A
was reported approximately 3:1, whereas that between
HigG and MEL-A was 1:70 as described above. This also
supports the multivalent effect of MEL-A toward the pro-
tein binding. In spite of these different binding mecha-
nisms, the observed binding constant for HIgG of MEL-
A is approximately 4-fold higher than that of the protein
A, and the binding capacity is nearly comparable be-
tween the two ligands. The bound amount of HIgG to the
composite increased with increases in the attached
amount of MEL-A, and the potential selectivity for HIgG
and HSA was obtained by modifying the buffer condi-
tions. The increase of MEL-A probably enhances the
density of an ordered conformation needed for the inter-
action with HIgG; this finally might impede the binding
of HSA. Therefore, the binding capacity and selectivity of
the composite would be improved with a greater at-
tached amount of MEL-A.
Nevertheless, the detailed binding mechanism between
MEL and HIgG is still obscure and remains to be clari-
fied. The approach for the mechanisms may also contrib-
ute to a better understanding of the glycolipid activities
against mammalian tumor cells. We are not aware of any
existing reports on the binding of a natural human anti-
body to a yeast extracellular glycolipid. The yeast glycol-
ipid, which is abundantly produced from vegetable oils,
may be a potential material for human IgG separation.
Materials and Methods
Materials
Polyclonal HIgG (purity 95 %), globulin free human se-
rum albumin (HSA), 5,5'-tetramethyl-benzidine dihy-
drochloride (TMB) and peroxidase-conjugated anti-
HIgG Fab fragment from goat were purchased from Sig-
ma Chemical Co. (St. Louis, USA). Peroxidase-conjugat-
ed anti-HIgG Fc fragment from goat was purchased from
Jackson Immunoresearch Laboratories Inc. (West
Grove, USA). GM1 from bovine brain and peroxidase-
conjugated anti-HIgG from rabbit were purchased from
Wako Pure Chemicals (Osaka, Japan). Other reagents
were of biochemical grade and were commercially avail-
able.
The mixture of MELs were produced from methyl tetra-
decanoate with a yeast strain of Candida antarctica T-34
[32], and purified by silica-gel column chromatography
as reported previously [17,18]. The purified 4-O-[(4', 6'-
di-O-acetyl-2', 3'-di-O-alkanoyl)-β -D-mannopyrano-
syl]meso-erythritol (MEL-A) (Fig. 1), which is the major
component of the yeast product, was exclusively used in
the following experiments. MEL-A (mean Mw: 676) is
sparingly soluble in water [33].
Assay for HIgG-glycolipid binding by ELISA
ELISA was performed according to the "noncovalent
method" used for small lipidic analytes [34]. Glycolipids
and antibodies were dissolved in methanol and in 10 mM
phosphate-buffered saline (PBS) (150 mM NaCl, pH 7.2),
respectively. Glycolipid solutions (100 µl) of different
concentrations were put into wells of microtiter plate,
and the plate was dried under a nitrogen stream; glycol-
ipids were then noncovalently bound inside the wells.
Washing was performed at every step with PBS-0.05 %
Tween 20.
1) The wells were blocked with 5 % bovine serum albu-
min for 1 hr; 2) incubated with 100 µl of HIgG solution
(10 µM) for 1 hr; 3) incubated with 100 µl of the peroxi-
dase-conjugated anti-HIgG solution (1.4 µg/ml) for 1 hr;
4) incubated with 100 µl of substrate solution (160 µM
Table 1: The effects of salt concentration and the pH of phos-
phate buffer on the protein binding to MEL-A attached onto pol-
yHEMA beads
Amount of protein bound
(mg/g composite a)
Salt(M) pH HIgG HSA
Control (0) 7.0 2.06 0.76
Na2SO4 (1.0) 4.0 3.93 1.95
5.6 3.63 1.12
6.4 3.45 0.73
7.0 2.87 1.20
7.5 3.73 1.28
NaCl (1.0) 7.0 2.35 0.53
a Composite bearing 2.99 mg of MEL-A per g of polyHEMA. The pro-
tein (1.0 mg) was added to the mixture of MEL-polyHEMA composite 
and 50 mM phosphate buffer (3 ml) in a polypropylene tube. The tube 
was incubated for 1 hr and then centrifuged. The amount of bound 
protein was calculated by subtracting that of unbound protein from 
the total added; the amount of unbound protein was estimated by 
measuring the UV absorbance of the supernatant. Each data is the 
mean of triplicate. MEL-A, mannosylerythritol lipid-A; polyHEMA, poly 
(2-hydroxyethyl methacylate); HIgG, human immunoglobulin G; HSA, 
human serum albumin.BMC Biotechnology 2001, 1:5 http://www.biomedcentral.com/1472-6750/1/5
TMB in acetate buffer, pH 5.6) for 5 min.; 5) incubated
with 25 µl of 1 M HCl to terminate the reaction. The op-
tical absorbance of each well was determined at 450 nm
using a microplate reader (Molecular Device, USA). In
the case of peroxidase-conjugated anti-HIgG Fab and
anti-HIgG Fc, the original reagent solution was used af-
ter being diluted to 1000-fold.
After each step, the washed solution was subjected to
thin-layer chromatography [12] to check the glycolipid
leak from the wells.
Attachment of MEL-A onto polyHEMA beads
In this study, poly (2-hydroxyethyl methacrylate) (poly-
HEMA), which is widely used for protein bindings due to
their biocompatibility and stability [35,36], was em-
ployed as a polymer supporting material for MEL. Poly-
HEMA beads (diameter: 50 to 150 µm) were synthesized
by the suspension polymerization method reported pre-
viously [36,37]. The weight of the beads was expressed in
terms of the dry weight in the following experiments.
Different amounts of MEL-A in methanol were charged
to the mixture of polyHEMA beads (0.35 ± 0.05 g) and
methanol (20 ml). All the solvent were then evaporated
by vigorous stirring under a nitrogen stream at room
temperature. The obtained residue was washed exten-
sively with water and filtrated to give MEL-A attached
onto polyHEMA beads (designated as MEL-polyHEMA
composite). The amount of MEL-A attached onto the
beads was determined by the previously described an-
throne method [38] after being extracted with a solvent
mixture of chloroform-methanol (2:1).
Assay for protein-MEL binding using MEL-polyHEMA 
composite
The binding studies between proteins and the composite
were conducted according to the method of Teng et al
[4]. HIgG or HSA (1.0 mg) was added to the mixture of
the composite (0.35 ± 0.05 g) bearing different amounts
of MEL-A and 3 ml of 50 mM phosphate buffer (pH 7.0)
in a polypropylene tube, unless otherwise indicated. The
tube was reciprocally incubated for 1 hr at room temper-
ature, and then centrifuged at 3,000 rpm for 20 min. The
amount of bound protein to the composite was calculat-
ed by subtracting that of unbound protein from the total
added; the amount of unbound protein was estimated by
measuring the UV absorbance at 280 nm of the superna-
tant.
Determination of the binding constant and capacity for 
HIgG of MEL-PHEMA composite
Different amounts of HIgG (0.1 to 12.0 mg) was added to
the mixture of the composite (0.35 ± 0.05 g) bearing 4.04
mg MEL-A per g of polyHEMA and 3 ml of 50 mM phos-
phate buffer (1 M of Na2SO4, pH 6.4) in the tube. The
amounts of bound and unbound HIgG were estimated by
the above method using UV measurement. The binding
constant and capacity were determined from the equa-
tion for the Langmuir adsorption isotherm [4], q = (Q
max K a C) / (1+ K a C), where q is the bound amount of
HIgG, C is the unbound concentration of HIgG, K a is the
binding constant and Q max is the binding capacity.
Abbreviations
ELISA, enzyme-linked immunosorbent assay; HIgG, hu-
man immunoglobulin G; HSA, human serum albumin;
IgM, immunoglobulin M; MEL, mannosylerythritol lip-
id; polyHEMA, poly(2-hydroxyethyl methacrylate); the
designation of ganglio-series gangliosides is according to
Svennerholm [39].
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